ProShare Advisors Portfolio holdings
AUM
$50.1B
1-Year Return
23.39%
This Quarter Return
-4.84%
1 Year Return
+23.39%
3 Year Return
+95.6%
5 Year Return
+167.57%
10 Year Return
+417.51%
AUM
$46.6B
AUM Growth
-$4.41B
(-8.6%)
Cap. Flow
-$936M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
31.78%
Holding
2,365
New
27
Increased
297
Reduced
1,868
Closed
169
Top Buys
| 1 |
Brown & Brown
BRO
|
+$173M |
| 2 |
Church & Dwight Co
CHD
|
+$150M |
| 3 |
Advanced Micro Devices
AMD
|
+$72.3M |
| 4 |
AstraZeneca
AZN
|
+$58.8M |
| 5 |
Old Dominion Freight Line
ODFL
|
+$54.6M |
Top Sells
| 1 |
Apple
AAPL
|
+$176M |
| 2 |
Microsoft
MSFT
|
+$139M |
| 3 |
AT&T
T
|
+$137M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$110M |
| 5 |
Amazon
AMZN
|
+$91.6M |
Sector Composition
| 1 | Technology | 31.53% |
| 2 | Consumer Discretionary | 13.24% |
| 3 | Communication Services | 9.89% |
| 4 | Healthcare | 9.39% |
| 5 | Consumer Staples | 8.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2001
SIGA Technologies
SIGA
$620M
| $118K | ﹤0.01% |
16,717
-4,263
| -20% | -$30.1K |
|
2002
Organogenesis Holdings
ORGO
$605M
| $117K | ﹤0.01% |
15,211
+4,905
| +48% | +$37.7K |
|
|
VVNT
2003
DELISTED
Vivint Smart Home, Inc. Class A Common Stock
VVNT
| $116K | ﹤0.01% |
17,181
-2,833
| -14% | -$19.1K |
|
2004
Douglas Elliman
DOUG
$240M
| $115K | ﹤0.01% |
16,551
-2,477
| -13% | -$17.2K |
|
|
VXRT
2005
DELISTED
Vaxart
VXRT
| $115K | ﹤0.01% |
22,951
-3,785
| -14% | -$19K |
|
2006
IDEAYA Biosciences
IDYA
$2.05B
| $114K | ﹤0.01% |
10,125
-2,451
| -19% | -$27.6K |
|
2007
Ocugen
OCGN
$322M
| $114K | ﹤0.01% |
34,651
-5,693
| -14% | -$18.7K |
|
2008
Praxis Precision Medicines
PRAX
$858M
| $112K | ﹤0.01% |
730
-176
| -19% | -$27K |
|
2009
Ocular Therapeutix
OCUL
$2.21B
| $111K | ﹤0.01% |
22,316
-5,216
| -19% | -$25.9K |
|
|
GOEV
2010
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $110K | ﹤0.01% |
43
-8
| -16% | -$20.5K |
|
|
VRAY
2011
DELISTED
ViewRay, Inc.
VRAY
| $110K | ﹤0.01% |
28,218
-2,024
| -7% | -$7.89K |
|
2012
Immunovant
IMVT
$2.85B
| $108K | ﹤0.01% |
19,654
-5,301
| -21% | -$29.1K |
|
2013
OraSure Technologies
OSUR
$238M
| $108K | ﹤0.01% |
15,926
-1,966
| -11% | -$13.3K |
|
2014
Ouster
OUST
$1.65B
| $108K | ﹤0.01% |
2,392
-1,036
| -30% | -$46.8K |
|
|
DBD
2015
DELISTED
Diebold Nixdorf Incorporated
DBD
| $108K | ﹤0.01% |
16,034
-1,973
| -11% | -$13.3K |
|
2016
Day One Biopharmaceuticals
DAWN
$765M
| $106K | ﹤0.01% |
10,675
-452
| -4% | -$4.49K |
|
2017
Omeros
OMER
$287M
| $106K | ﹤0.01% |
17,779
-4,205
| -19% | -$25.1K |
|
2018
Ambac
AMBC
$426M
| $105K | ﹤0.01% |
10,144
-1,248
| -11% | -$12.9K |
|
2019
Dyne Therapeutics
DYN
$1.89B
| $105K | ﹤0.01% |
10,966
-2,853
| -21% | -$27.3K |
|
2020
Immersion
IMMR
$231M
| $105K | ﹤0.01% |
+18,874
| New | +$105K |
|
2021
Sutro Biopharma
STRO
$83.3M
| $105K | ﹤0.01% |
12,929
-3,061
| -19% | -$24.9K |
|
|
FMTX
2022
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $105K | ﹤0.01% |
11,275
-2,823
| -20% | -$26.3K |
|
2023
Fossil Group
FOSL
$160M
| $103K | ﹤0.01% |
10,602
-1,318
| -11% | -$12.8K |
|
2024
Generation Bio
GBIO
$39.3M
| $103K | ﹤0.01% |
1,412
-344
| -20% | -$25.1K |
|
|
CMRX
2025
DELISTED
Chimerix, Inc.
CMRX
| $103K | ﹤0.01% |
22,685
-5,494
| -19% | -$24.9K |
|